750
Participants
Start Date
October 21, 2024
Primary Completion Date
January 31, 2030
Study Completion Date
January 31, 2030
LY4066434.
Administered orally.
Cetuximab
Administered intravenously.
Nab paclitaxel
Administered intravenously.
Gemcitabine
Administered intravenously.
Oxaliplatin
Administered intravenously.
Leucovorin
Administered intravenously.
Irinotecan
Administered intravenously.
5Fluorouracil
Administered intravenously.
Carboplatin
Administered intravenously.
Cisplatin
Administered intravenously.
Pemetrexed
Administered intravenously.
Pembrolizumab
Administered intravenously.
RECRUITING
Universite Libre de Bruxelles (ULB) - Institut Jules Bordet, Brussels
RECRUITING
Cliniques universitaires Saint-Luc, Brussels
RECRUITING
UZ Gent, Ghent
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Columbia University, New York
RECRUITING
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
NOT_YET_RECRUITING
Charite Universitaetsmedizin Berlin, Berlin
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
Virginia Cancer Specialists, Fairfax
RECRUITING
Asklepios Kliniken Hamburg GmbH - Asklepios Klinik Altona, Hamburg
RECRUITING
Duke University Medical Center, Durham
NOT_YET_RECRUITING
Hospital General Universitario Gregorio Maranon, Madrid
RECRUITING
Hospital Universitario Ramon y Cajal, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Regional Universitario de Malaga, Málaga
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Centro Ricerche Cliniche di Verona s.r.l., Verona
RECRUITING
Sarah Cannon Research Institute/SCRI, Nashville
RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Indiana University (IU), Indianapolis
RECRUITING
Henry Ford Health System, Detroit
RECRUITING
South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
NOT_YET_RECRUITING
Mayo Clinic - Rochester, Rochester
RECRUITING
Krankenhaus Nordwest GmbH, Frankfurt
NOT_YET_RECRUITING
The University of Chicago Medical Center (UCMC), Chicago
NOT_YET_RECRUITING
Centre Leon Berard, Lyon
NOT_YET_RECRUITING
University of Oklahoma - Health Sciences Center, Oklahoma City
RECRUITING
SLK-Kliniken Heilbronn GmBH, Heilbronn
RECRUITING
University of Texas Southwestern, Dallas
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
South Texas Accelerated Research Therapeutics (START), San Antonio
NOT_YET_RECRUITING
University of Colorado Denver, Denver
RECRUITING
Mayo Clinic, Phoenix
RECRUITING
University of California, Los Angeles (UCLA), Los Angeles
RECRUITING
City of Hope, Duarte
NOT_YET_RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Universitaetsklinikum Wuerzburg, Würzburg
RECRUITING
Swedish Cancer Institute (SCI), Seattle
NOT_YET_RECRUITING
Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing
NOT_YET_RECRUITING
Shandong Province Tumor Hospital, Jinan
NOT_YET_RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
National Taiwan University Hospital Hsin-Chu Branch, Hsinchu
NOT_YET_RECRUITING
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
RECRUITING
Yale University School of Medicine - Yale Cancer Center, New Haven
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
NOT_YET_RECRUITING
Shanghai East Hospital, Tongji University, Shanghai
RECRUITING
National Cancer Center Hospital East, Chiba
RECRUITING
Kyoto University Hospital, Kyoto
RECRUITING
Shizuoka Cancer Center, Shizuoka
RECRUITING
National Cancer Center Hospital, Tokyo
RECRUITING
Cancer Institute Hospital of JFCR, Tokyo
RECRUITING
Hospital del Mar, Barcelona
RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
RECRUITING
Institut Catala d'Oncologia - L'Hospitalet, Barcelona
Eli Lilly and Company
INDUSTRY